Helus Pharma HELP
Helus Pharma changes name to Helus Pharma
Foreign issuer report
- Form
- 6-K
- Filed
- Importance
- Routine
- Accession
- 0001833141-26-000087
- Name change from Cybin Inc. to Helus Pharma effective Oct 1, 2026
- Approved by shareholders on Sep 22, 2026
- Shares continue to trade under ticker HELP
- New CUSIP: 423,492,107, New ISIN: CA4234921076
Written from the 6-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- America Great Health AAGH
- AbbVie ABBV public float $325.1B, Jun 30, 2025
- Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
- Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
- Arbutus Biopharma ABUS public float $472M, Jun 30, 2025
